Which markets do you export to?

We export to North America, South America, Europe, Asia, Africa, Oceania, and the Middle East.

Is the product derived from natural sources?

Yes, the resource is natural, specifically extracted from apple tree bark.

What packaging material is used?

The product is packaged using paper material.

Apple Tree Bark Extract High Quality Nutrition

Name: Apple Tree Bark Extract High Quality Nutrition
Brand: Puyer Biopharma Ltd.
SKU: 2155935665

Jiangsu, ChinaPuyer Biopharma Ltd.

US$15.00-35.00

1 kg

Sample price:US$50.00/piece.Request sample

Product profile

Customization

Available

CAS No.

N/a

Formula

N/a

Model NO.

plant extract

EINECS

N/a

Packaging Material

Paper

Storage Method

Normal

Shelf Life

>12 Months

Nutrient Composition

Plant Extract

Resource

Natural

The content of active substances

＞90%

Transport Package

Drum

Specification

99%

Trademark

PUYER

Origin

China

Production Capacity

100000kg/Month

Key features

High Purity Content: Active substance content exceeds 90%, ensuring high quality nutrition.

Natural Plant Source: Derived from natural apple tree bark, rich in bioactive compounds.

Antioxidant Benefits: Contains polyphenols and carotenoids to neutralize free radicals.

Long Shelf Life: Stable formula with a shelf life exceeding 12 months.

Cardiovascular Support: Helps improve heart health by reducing blood pressure and cholesterol.

Global Export Capability: Exports to North America, Europe, Asia, and other global markets.

Flexible Payment Terms: Accepts LC, T/T, PayPal, Western Union, and other secure methods.

Fast Lead Time: Off-season delivery within 15 workdays for quick turnaround.

Company profile

Puyer Biopharma Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading Company, OtherExport Year: 2016-08-01Nearest Port: shanghai, qingdao, tianjinAverage Response Time: ≤10.77hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA, EXW

AI-Powered supplier vetting

SummaryPuyer Biopharma Ltd. is identified as a China-based limited company operating from Nantong, Jiangsu, with manufacturer/factory and trading-company classifications. Its stated scope covers APIs, intermediates, fine chemicals, nutraceuticals, crop science, animal health, and related services. Evidence indicates ISO 9001 certification, 21–30 years of combined R&D engineer experience, 6–10 quality-control staff, 10 production lines, batch production of more than 300 products, and multiple production or testing locations. The supplier exports independently, began exporting in 2016, and reports broad international market coverage. However, the provided information does not establish after-sales service processes, financial credibility, customization execution, or named customer cases. Indexes 8 and 9 identify a different entity, Tieling Municipal People’s Government, and are excluded from supplier conclusions.

Supplier typeThe supplier is described as a factory, manufacturer, and trading company. Puyer Biopharma Ltd. is a China-based limited company located in Nantong, Jiangsu, and its stated business covers production, R&D, and sales of pharmaceutical, chemical, nutrition, agricultural, and related products.

CertificationsThe supplier explicitly reports ISO 9001 certification for its management system. This provides direct evidence of a recognized quality-management certification, although no additional certifications are stated.

R&D capabilityPuyer is described as a high-tech enterprise founded by doctors and specializing in R&D, with 21–30 years of R&D engineer experience. It reports laboratories, testing centers, production bases, and investment in R&D testing and production equipment, directly supporting substantial innovation and technical-development capability.

Production capacityThe supplier reports 10 production lines, batch production of more than 300 products, multiple production bases, and stated annual capacities for salicylic acid, potassium humate, amino acid powder, dicalcium phosphate, and choline chloride. These figures provide explicit evidence of broad and sizable production capability.